Atossa Therapeutics, Inc.ATOSNASDAQ
LOADING
|||
Gross Profit Growth Trend
Above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
0.00%
↑ 100% above average
Average (39q)
-14.51%
Historical baseline
Range
High:100.00%
Low:-556.42%
Volatility
-4523.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 20.00% |
| Q1 2024 | 64.29% |
| Q4 2023 | -366.67% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -50.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | -15.27% |
| Q4 2021 | 72.09% |
| Q3 2021 | -7.32% |
| Q2 2021 | 37.41% |
| Q1 2021 | 0.00% |
| Q4 2020 | 26.28% |
| Q3 2020 | -1.36% |
| Q2 2020 | -0.48% |
| Q1 2020 | 1.39% |
| Q4 2019 | 1.88% |
| Q3 2019 | 6.09% |
| Q2 2019 | 2.98% |
| Q1 2019 | 9.83% |
| Q4 2018 | -42.90% |
| Q3 2018 | -8.80% |
| Q2 2018 | -26.85% |
| Q1 2018 | 70.79% |
| Q4 2017 | 6.80% |
| Q3 2017 | 12.75% |
| Q2 2017 | 17.42% |
| Q1 2017 | 47.32% |
| Q4 2016 | -1.71% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 100.00% |
| Q4 2015 | -556.42% |